Musk posted on social media that Neuralink’s Blindsight product is currently awaiting regulatory approval. The product description he cited characterizes it as a neural implant device that directly connects to the visual cortex, designed to provide visual information to the blind. The post did not specify the regulatory agency awaiting approval, the application category, or a timeline; this is not an announcement that the product has been approved or that the efficacy of restoring vision has been clinically proven.